Krishna Institute of Medical Sciences Limited (KIMS.BO)
INR 659.15
(0.27%)
INR 659.15
(0.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.58 Billion INR | 75.29% |
| 2022 | 10.03 Billion INR | 102.0% |
| 2021 | 4.96 Billion INR | -11.3% |
| 2020 | 5.59 Billion INR | -4.19% |
| 2019 | 5.84 Billion INR | 5.73% |
| 2018 | 5.52 Billion INR | -49.57% |
| 2017 | 10.96 Billion INR | 148.69% |
| 2016 | 4.4 Billion INR | 11.45% |
| 2015 | 3.95 Billion INR | -4.2% |
| 2014 | 4.12 Billion INR | -5.06% |
| 2013 | 4.34 Billion INR | 16.36% |
| 2012 | 3.73 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -20.93 Billion INR | -219.02% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 17.58 Billion INR | 0.0% |
| 2023 FY | 17.58 Billion INR | 75.29% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 13.34 Billion INR | 0.0% |
| 2022 Q2 | 8.41 Billion INR | 0.0% |
| 2022 Q4 | 10.03 Billion INR | 0.0% |
| 2022 FY | 10.03 Billion INR | 102.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 4.96 Billion INR | -11.3% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 4.96 Billion INR | 0.0% |
| 2021 Q2 | 3.99 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | 5.62 Billion INR | 0.0% |
| 2020 FY | 5.59 Billion INR | -4.19% |
| 2020 Q4 | 5.59 Billion INR | -0.42% |
| 2019 Q4 | 5.84 Billion INR | 0.0% |
| 2019 FY | 5.84 Billion INR | 5.73% |
| 2018 FY | 5.52 Billion INR | -49.57% |
| 2017 Q2 | 4.56 Billion INR | 0.0% |
| 2017 Q1 | 4.56 Billion INR | 0.0% |
| 2017 FY | 10.96 Billion INR | 148.69% |
| 2016 FY | 4.4 Billion INR | 11.45% |
| 2015 FY | 3.95 Billion INR | -4.2% |
| 2014 FY | 4.12 Billion INR | -5.06% |
| 2013 FY | 4.34 Billion INR | 16.36% |
| 2012 FY | 3.73 Billion INR | 0.0% |